Regional haemodynamic effects of mu-, delta-, and kappa-opioid agonists microinjected into the hypothalamic paraventricular nuclei of conscious, unrestrained rats
Autor: | Maryse Pitre, Hélène Bachelard |
---|---|
Jazyk: | angličtina |
Rok vydání: | 1995 |
Předmět: |
Male
medicine.medical_specialty Pyrrolidines Enkephalin Microinjections Receptors Opioid mu Vasodilation Blood Pressure Rats Inbred WKY chemistry.chemical_compound Renal Artery Heart Rate Internal medicine Receptors Opioid delta Tachycardia medicine Laser-Doppler Flowmetry Animals Opioid peptide Mesenteric arteries Antihypertensive Agents Pharmacology Analgesics Receptors Opioid kappa digestive oral and skin physiology 3 4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide (trans)-Isomer Hemodynamics Enkephalins Enkephalin Ala(2)-MePhe(4)-Gly(5) Hindlimb Mesenteric Arteries Rats DAMGO medicine.anatomical_structure Endocrinology chemistry Opioid nervous system Hypothalamus Vasoconstriction medicine.symptom Enkephalin D-Penicillamine (2 5) hormones hormone substitutes and hormone antagonists medicine.drug Research Article Paraventricular Hypothalamic Nucleus |
Popis: | 1. The cardiovascular effects of bilateral injection into the hypothalamic paraventricular nuclei of selective mu-, delta-, and kappa-opioid receptor agonists were investigated in conscious, unrestrained Wistar Kyoto rats, chronically instrumented with pulsed Doppler flow probes for measurement of regional haemodynamics. 2. The selective mu-agonist [D-Ala2,MePhe4,Gly5ol]enkephalin (DAMGO), injected bilaterally into the hypothalamic paraventricular nuclei (0.01-1.0 nmol), caused increases in blood pressure, tachycardias, vasoconstriction in renal and superior mesenteric vascular beds and substantial vasodilatation in the hindquarter vascular bed. 3. The administration of increasing doses (0.01-5.0 nmol) of the selective delta-agonist [D-Phe2,5]enkephalin (DPDPE) or the selective kappa-agonist, U50488H into the paraventricular nuclei (PVN) had no significant effect on blood pressure, heart rate, or regional haemodynamics. 4. Together, the present results are further evidence of a role for opioid peptides, especially acting at mu-receptors in the PVN, in the central regulation of the cardiovascular system, whereas a role for opioid peptides, acting at delta- and kappa-receptors in the PVN, seems less obvious from the present results. |
Databáze: | OpenAIRE |
Externí odkaz: |